Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Spinogenix has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Spinogenix's investors include National Institutes of Health, U.S. Department of Defense.
Spinogenix is headquartered in San Diego, United States.
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Spinogenix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spinogenix — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/spinogenix. Accessed July 19, 2026.
VCBacked. (2024). Spinogenix — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/spinogenix
{{cite web |title=Spinogenix — Funding & Investors |url=https://www.vcbacked.co/company/spinogenix |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated